Publications by authors named "Christopher McConkey"

Claim this Profile
R
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Hisham Mehanna, Max Robinson, Andrew Hartley, Anthony Kong, Bernadette Foran, Christopher McConkey

Lancet· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of institutional clinical trial recruitment versus hospital volume on survival outcomes of patients with head and neck cancer: An analysis of the PET-NECK trial outcomes, UKCRN portfolio, and Hospital Episode Statistics (HES) in England.
Daniel J Lin, Christopher C McConkey, Paul Nankivell, Janet Dunn, Hisham Mehanna

Oral Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hand exercises for patients with rheumatoid arthritis: an extended follow-up of the SARAH randomised controlled trial.
Esther Williamson, Christopher McConkey, Peter Heine, Sukhdeep Dosanjh, Mark Williams

BMJ Open· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.
Hisham Mehanna, Wai-Lup Wong, Christopher C McConkey, Joy K Rahman, Max Robinson

N Engl J Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.
John M S Bartlett, Christopher C McConkey, Alison F Munro, Christine Desmedt, Janet A Dunn

J Clin Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengthening And stretching for Rheumatoid Arthritis of the Hand (SARAH). A randomised controlled trial and economic evaluation.
Mark A Williams, Esther M Williamson, Peter J Heine, Vivien Nichols, Matthew J Glover, Christopher McConkey

Health Technol Assess· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial.
Sarah E Lamb, Esther M Williamson, Peter J Heine, Jo Adams, Sukhdeep Dosanjh, Christopher McConkey

Lancet· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.
Paul Nankivell, Hazel Williams, Keith Webster, David Pearson, Alec High, Christopher McConkey

J Oral Pathol Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region.
Hisham Mehanna, Tom Beech, Tom Nicholson, Iman El-Hariry, Christopher McConkey

Head Neck· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revising the radiobiological model of synchronous chemotherapy in head-and-neck cancer: a new analysis examining reduced weighting of accelerated repopulation.
Sara Meade, Paul Sanghera, Christopher McConkey, Jack Fowler, George Fountzilas

Int J Radiat Oncol Biol Phys· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The binary oral dysplasia grading system: validity testing and suggested improvement.
Paul Nankivell, Hazel Williams, Paul Matthews, Sari Suortamo, David Snead, Christopher McConkey

Oral Surg Oral Med Oral Pathol Oral Radiol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengthening and stretching for rheumatoid arthritis of the hand (SARAH): design of a randomised controlled trial of a hand and upper limb exercise intervention--ISRCTN89936343.

BMC Musculoskelet Disord· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in laryngeal dysplasia: a systematic review.
Paul Nankivell, Matthew Weller, Christopher McConkey, Vinidh Paleri, Hisham Mehanna

Head Neck· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
Rachel S Midgley, Christopher C McConkey, Elaine C Johnstone, Janet A Dunn, Justine L Smith

J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).
John M S Bartlett, Alison F Munro, Janet A Dunn, Christopher McConkey, Sarah Jordan

Lancet Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis.
Hisham M Mehanna, Tim Rattay, Joel Smith, Christopher C McConkey

Head Neck· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

Lancet· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
David J Kerr, Janet A Dunn, Michael J Langman, Justine L Smith, Rachel S J Midgley, Christopher C McConkey

N Engl J Med· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses.
Donald W Milligan, Savio Fernandes, Ranjit Dasgupta, Faith E Davies, Estella Matutes, Christopher McConkey

Blood· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome.
Paul G Murray, David Lissauer, Jia Junying, Gillian Davies, Sukhjinder Moore, Christopher McConkey

Cancer Res· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis